Nordea Investment Management AB boosted its stake in shares of Exponent Inc. (NASDAQ:EXPO) by 86.9% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 21,893 shares of the company’s stock after buying an additional 10,181 shares during the period. Nordea Investment Management AB owned approximately 0.08% of Exponent worth $1,118,000 at the end of the most recent reporting period.
Several other institutional investors have also recently modified their holdings of the stock. GW&K Investment Management LLC raised its position in shares of Exponent by 17.2% in the second quarter. GW&K Investment Management LLC now owns 316,076 shares of the company’s stock valued at $18,462,000 after buying an additional 46,418 shares during the period. California Public Employees Retirement System raised its position in shares of Exponent by 2.1% in the second quarter. California Public Employees Retirement System now owns 107,800 shares of the company’s stock valued at $6,297,000 after buying an additional 2,200 shares during the period. Goldman Sachs Group Inc. raised its position in shares of Exponent by 84.4% in the first quarter. Goldman Sachs Group Inc. now owns 23,143 shares of the company’s stock valued at $1,181,000 after buying an additional 10,594 shares during the period. Swiss National Bank raised its position in shares of Exponent by 1.2% in the second quarter. Swiss National Bank now owns 43,600 shares of the company’s stock valued at $2,547,000 after buying an additional 500 shares during the period. Finally, 1st Global Advisors Inc. raised its position in shares of Exponent by 78.8% in the second quarter. 1st Global Advisors Inc. now owns 7,946 shares of the company’s stock valued at $464,000 after buying an additional 3,501 shares during the period. 92.79% of the stock is currently owned by institutional investors and hedge funds.
Exponent Inc. (NASDAQ:EXPO) traded up 0.72% during midday trading on Friday, reaching $62.90. The company had a trading volume of 39,918 shares. The company has a market capitalization of $1.61 billion, a PE ratio of 36.36 and a beta of 0.65. Exponent Inc. has a 12-month low of $44.82 and a 12-month high of $63.30. The stock has a 50-day moving average price of $56.50 and a 200 day moving average price of $53.60.
Exponent (NASDAQ:EXPO) last posted its quarterly earnings data on Wednesday, October 19th. The company reported $0.42 EPS for the quarter, topping the Zacks’ consensus estimate of $0.34 by $0.08. Exponent had a return on equity of 15.72% and a net margin of 15.06%. The firm had revenue of $77.60 million for the quarter, compared to analyst estimates of $74.46 million. During the same quarter last year, the company earned $0.43 EPS. The company’s revenue was down .4% on a year-over-year basis. Equities analysts forecast that Exponent Inc. will post $1.70 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 23rd. Shareholders of record on Friday, December 2nd will be paid a dividend of $0.18 per share. The ex-dividend date is Wednesday, November 30th. This represents a $0.72 dividend on an annualized basis and a yield of 1.14%. Exponent’s dividend payout ratio (DPR) is presently 41.86%.
Several equities analysts have recently issued reports on EXPO shares. Cantor Fitzgerald started coverage on Exponent in a research note on Friday, August 26th. They set a “buy” rating and a $57.00 price target on the stock. Zacks Investment Research raised Exponent from a “hold” rating to a “strong-buy” rating and set a $66.00 price target on the stock in a research note on Monday, October 24th.
In other news, insider Harri Kytomaa sold 5,500 shares of Exponent stock in a transaction on Monday, November 14th. The stock was sold at an average price of $61.91, for a total value of $340,505.00. Following the transaction, the insider now owns 11,371 shares in the company, valued at approximately $703,978.61. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Michael R. Gaulke sold 4,000 shares of Exponent stock in a transaction on Wednesday, November 9th. The shares were sold at an average price of $59.55, for a total value of $238,200.00. The disclosure for this sale can be found here. Company insiders own 3.50% of the company’s stock.
Exponent, Inc, along with its subsidiaries, is a science and engineering consulting company. The Company operates through two segments: Engineering and Other Scientific, and Environmental and Health. Its Engineering and Other Scientific segment includes biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, engineering management consulting, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, technology development, thermal sciences and vehicle analysis services.